当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析 - 现金流量表

新华制药

(000756)

  

流通市值:77.49亿  总市值:108.50亿
流通股本:4.93亿   总股本:6.90亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,759,173,328.33,806,443,339.791,781,364,260.927,941,398,602.27
  收到的税费返还57,238,889.5134,313,637.8318,190,948.95155,876,316.01
  收到其他与经营活动有关的现金41,299,954.136,470,462.7135,770,336.6293,054,265.57
  经营活动现金流入小计5,857,712,171.913,877,227,440.331,835,325,546.498,190,329,183.85
  购买商品、接受劳务支付的现金4,252,434,435.682,782,539,243.671,351,404,814.185,601,050,514.46
  支付给职工以及为职工支付的现金763,390,417.43534,879,287.39271,516,877.181,058,575,737.05
  支付的各项税费170,288,449.73105,157,989.9254,142,412.23252,081,164.63
  支付其他与经营活动有关的现金349,600,006.1220,518,566.62149,836,252.8911,011,318.76
  经营活动现金流出小计5,535,713,308.943,643,095,087.61,826,900,356.397,822,718,734.9
  经营活动产生的现金流量净额321,998,862.97234,132,352.738,425,190.1367,610,448.95
二、投资活动产生的现金流量:
  取得投资收益收到的现金8,515,076.83,115,076.81,495,894.48,182,200
  处置固定资产、无形资产和其他长期资产收回的现金净额735,731.49439,943.8961,943.89654,705
  收到的其他与投资活动有关的现金1,473,78013,4408,603,760-
  投资活动现金流入小计10,724,588.293,568,460.6910,161,598.298,836,905
  购建固定资产、无形资产和其他长期资产支付的现金103,668,229.9376,807,920.6849,094,672.29212,421,547.59
  支付其他与投资活动有关的现金3,000,0003,000,00011,603,7608,626,080
  投资活动现金流出小计106,668,229.9379,807,920.6860,698,432.29221,047,627.59
  投资活动产生的现金流量净额-95,943,641.64-76,239,459.99-50,536,834-212,210,722.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金55,577,524.555,577,524.555,577,524.563,259,085.5
  取得借款收到的现金749,800,000459,800,000134,800,000860,307,702.93
  收到其他与筹资活动有关的现金5,260,0002,000,0001,000,00055,611,732.35
  筹资活动现金流入小计810,637,524.5517,377,524.5191,377,524.5979,178,520.78
  偿还债务支付的现金842,677,569.79622,977,569.79106,524,677.21552,058,243.97
  分配股利、利润或偿付利息支付的现金210,599,035.0330,301,466.88767,197.22240,352,752.05
  其中:子公司支付给少数股东的股利、利润8,982,0008,982,000-14,505,663.43
  支付其他与筹资活动有关的现金1,477,894.87814,747.45290,144.511,988,950.58
  筹资活动现金流出小计1,054,754,499.69654,093,784.12107,582,018.94794,399,946.6
  筹资活动产生的现金流量净额-244,116,975.19-136,716,259.6283,795,505.56184,778,574.18
四、汇率变动对现金及现金等价物的影响6,124,226.965,778,620.843,506,892.9515,012,454.65
五、现金及现金等价物净增加额-11,937,526.926,955,253.9645,190,754.61355,190,755.19
  加:期初现金及现金等价物余额1,136,875,010.061,136,875,010.061,136,875,010.06781,684,254.87
  期末现金及现金等价物余额1,124,937,483.161,163,830,264.021,182,065,764.671,136,875,010.06
补充资料:
  净利润-231,168,471.79-486,714,573.88
  资产减值准备-50,287,533.79-51,613,568.72
  固定资产和投资性房地产折旧-250,047,274.54-488,620,589.31
  无形资产摊销-31,067,568.57-50,223,901.76
  长期待摊费用摊销-2,348,380.85-4,726,630.46
  处置固定资产、无形资产和其他长期资产的损失--1,711,209.17--1,419,533.61
  固定资产报废损失-236,486.07-5,045,910.64
  财务费用-15,670,470.77-24,726,825.12
  投资损失--5,879,082.58--9,836,416.05
  递延所得税-5,365,550.9-14,752,093.29
  其中:递延所得税资产减少-6,856,749.64--1,442,340.18
    递延所得税负债增加--1,491,198.74-16,194,433.47
  存货的减少--6,560,276.59--11,431,347.68
  经营性应收项目的减少--427,595,333.26--629,942,578.49
  经营性应付项目的增加-72,201,697.84--153,629,238.13
  其他-7,568,060.46-35,882,504
  现金的期末余额-1,163,830,264.02-1,136,875,010.06
  减:现金的期初余额-1,136,875,010.06-781,684,254.87
  现金及现金等价物的净增加额-26,955,253.96-355,190,755.19
公告日期2025-10-252025-08-272025-04-292025-03-31
审计意见(境内)标准无保留意见
TOP↑